Incanthera Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Incanthera Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11335
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The company’s pipeline drug candidates include ICT01-2588, a vascular disrupting agent, based on the tumor-blasting technology; ICT03 – Es5, a potent bioreductive anticancer agent, which are targeted at destroying all forms of solid tumors; ICT04-CYP, that target on colorectal cancer. Incanthera assists the commercialization of the drug development and licensing these to large pharmaceutical companies. The company provides technology and products in the field of oncology and diagnostics. It operates research laboratory in Bradford, West Yorkshire. Incanthera is headquartered in Manchester, the UK.

Incanthera Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incanthera Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Incanthera Acquires Drug Development Programme from University of Bradford 10
Venture Financing 11
Incanthera Raises USD2 Million in Financing Round 11
Incanthera Raises US$1 Million In Venture Financing 12
Incanthera Raises US$0.6 Million In Venture Financing 13
Partnerships 14
ImmuPharma to Enter into Partnership with Incanthera 14
Licensing Agreements 15
Incanthera Enters into Licensing Agreement for ICT01-2588 15
Acquisition 16
Incanthera Acquires Spear Therapeutics 16
Incanthera Acquires Onco-NX, Drug Discovery Company 17
Incanthera Ltd – Key Competitors 18
Incanthera Ltd – Key Employees 19
Incanthera Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Incanthera Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incanthera Acquires Drug Development Programme from University of Bradford 10
Incanthera Raises USD2 Million in Financing Round 11
Incanthera Raises US$1 Million In Venture Financing 12
Incanthera Raises US$0.6 Million In Venture Financing 13
ImmuPharma to Enter into Partnership with Incanthera 14
Incanthera Enters into Licensing Agreement for ICT01-2588 15
Incanthera Acquires Spear Therapeutics 16
Incanthera Acquires Onco-NX, Drug Discovery Company 17
Incanthera Ltd, Key Competitors 18
Incanthera Ltd, Key Employees 19
Incanthera Ltd, Other Locations 20
Incanthera Ltd, Subsidiaries 20

List of Figures
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Incanthera Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wheelock and Company Limited :企業の戦略・SWOT・財務情報
    Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report Summary Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pasteur Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Pasteur Institute is a non-profit foundation that provides research, health services and teaching services. The foundation conducts research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structura …
  • CGU Insurance Ltd:企業の戦略・SWOT・財務分析
    CGU Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary CGU Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biovista Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biovista Inc (Biovista) is a drug development company that provides COSS platform technology support in uncovering non-obvious correlations between drugs. The company’s products are used for the treatment of neurodegenerative diseases, epilepsy, oncology and orphan diseases. It offers servic …
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • China Minsheng Banking Corp Ltd:戦略・SWOT・企業財務分析
    China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Eizo Corp (6737):企業の財務・戦略的SWOT分析
    Eizo Corp (6737) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ventana Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • GROUPE ADEO SA:戦略・SWOT・企業財務分析
    GROUPE ADEO SA - Strategy, SWOT and Corporate Finance Report Summary GROUPE ADEO SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Trinity Biotech Plc (TRIB):医療機器:M&Aディール及び事業提携情報
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • National Grid Plc:企業の発電所・SWOT分析2018
    National Grid Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Toda Corporation:企業の戦略・SWOT・財務分析
    Toda Corporation - Strategy, SWOT and Corporate Finance Report Summary Toda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Greif, Inc. (GEF):企業の財務・戦略的SWOT分析
    Greif, Inc. (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • TUI AG (TUI1):企業の財務・戦略的SWOT分析
    TUI AG (TUI1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Eupraxia Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eupraxia Pharmaceuticals Inc (Eupraxia Pharma) is a drug development company that offers pain management solutions. The company’s technology encapsulates pharmaceutical micro particles in a polymer shell which helps to extend drug release from days to months. Its pipeline products include EP …
  • Genomma Lab Internacional SAB de CV (LABB):企業の財務・戦略的SWOT分析
    Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Stratos Product Development LLC-医療機器分野:企業M&A・提携分析
    Summary Stratos Product Development LLC (Stratos) is a provider of product development solutions. The company offers medical product development, and product design and strategy services. It offers services which include product strategy, research, industrial design and interaction design. The compa …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務分析
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Levi Strauss & Co (LEVI):企業の財務・戦略的SWOT分析
    Levi Strauss & Co (LEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆